ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
ThinkEquity Starts Ellie Mae (ELLI) at Buy
-
ThinkEquity Starts Callidus Software (CALD) at Buy
-
ThinkEquity Starts salesforce.com (CRM) at Buy
-
ThinkEquity Cuts PT on F5 Networks (FFIV) to $122, Maintains 'Buy'
-
Notable Analyst Rating Changes 07/11: (SKYW) (SAP) (AMCX) Upgraded; (DNDN) (WM) (HUN) Downgraded
-
ThinkEquity Starts PICO Holdings (PICO) at Buy
-
ThinkEquity Upgrades SAP AG (SAP) to Buy
-
SAP (SAP) Shares Rise as ThinkEquity Upgrades to Buy
-
OraSure (OSUR) Commences $75M Common Offering
-
OraSure (OSUR) Prices 6.1M Offering at $12.30/Share
-
OraSure (OSUR) Announces Offering of $75M in Common Shares
-
Notable Analyst Rating Changes 07/05: (BX) (YNDX) (TKC) Upgraded; (AMD) (MT) (BAM) Downgraded
-
ThinkEquity Starts Seattle Genetics (SGEN) at Buy
-
ThinkEquity Downgrades Symantec (SYMC) to Hold
-
Notable Analyst Rating Changes 06/29: (SKS) (BBBY) (ORCL) Upgraded; (RIMM) (NKE) (ANTH) Downgraded
-
ThinkEquity Starts AOL, Inc. (AOL) at Hold
-
ThinkEquity Starts Aegerion Pharmaceuticals (AEGR) at Buy
-
ThinkEquity Starts Synageva BioPharma (GEVA) at Buy
-
ThinkEquity Starts Raptor Pharmaceuticals (RPTP) at Buy
-
ThinkEquity Starts Amicus Therapeutics (FOLD) at Buy
-
ThinkEquity Starts Navidea Biopharmaceuticals (NAVB) at Buy
-
ThinkEquity Starts BioMarin Pharmaceutical Inc. (BMRN) at Buy
-
ThinkEquity Starts Corcept Therapeutics (CORT) at Buy
-
ThinkEquity Starts Medivation (MDVN) at Buy
-
Notable Analyst Rating Changes 06/28: (OREX) (HAL) (DRIV) Upgraded; (WFT) (MTL) (CBE) Downgraded
-
ThinkEquity Downgrades Seagate Technology (STX) to Hold
-
ThinkEquity Downgrades Western Digital Corp. (WDC) to Hold
-
ThinkEquity Upgrades Cree (CREE) to Buy
-
Sohu.com (SOHU) Shares Higher Following ThinkEquity Upgrade
-
ThinkEquity Downgrades QLogic (QLGC) to Hold
-
ThinkEquity Downgrades Emulex (ELX) to Hold
-
ThinkEquity Starts Cisco (CSCO) at Hold, Sets $18 Price Target
-
ThinkEquity Starts Masimo Corp. (MASI) at Buy
-
ThinkEquity Starts Solazyme (SZYM) at Buy
-
Notable Analyst Rating Changes 06/15: (NOK) (ORCL) (SAI) Upgraded; (EXC) (PBR) (AUY) Downgraded
-
UPDATE: ThinkEquity Upgrades Oracle (ORCL) to Buy; Calls Street Sentiment Too Bearish
-
OpenTable (OPEN) Upgraded to Buy at ThinkEquity; Shares Rise
-
Streetinsider.com's Hot Lunchtime Reads 06/11: (TWX) (NAV) (WPRT) GMCR) (FFIV)
-
iPhone 5 Will Create 'Significant' Upside in F5's (FFIV) North American Traffic -ThinkEquity
-
Whiting Leaving Brocade (BRCD) Could Create Uncertainty in Employee, Shareholder Bases -ThinkEquity
-
Notable Analyst Rating Changes 06/05: (FIO) (MRVL) (ZION) Upgraded; (BRCD) (JPM) (ASX) Downgraded
-
ThinkEquity Downgrades Brocade (BRCD) to Hold
-
ThinkEquity Upgrades Allot Communications (ALLT) to Buy, Raises Target to $30
-
ThinkEquity Starts Celldex Therapeutics (CLDX) at Buy
-
ThinkEquity Starts Pericom Semiconductor (PSEM) at Buy
-
ThinkEquity Starts Cavium Networks (CAVM) at Hold
-
ThinkEquity Starts Magnachip Semiconductor (MX) at Buy
-
ThinkEquity Starts Micron (MU), Spansion (CODE) at Buy, SanDisk (SNDK) at Hold
-
ThinkEquity Assumes Optimer Pharma (OPTR) at Buy, Sets $25 Price Target
-
Angie's List (ANGI) Lock-Up Expiration for Certain Shares Set for November 2011

